Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

Glioblastoma remains one of the most challenging solid tumors to treat due to its highly immunosuppressive tumor microenvironment.

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

This work not only identified the genetic cause of RP but also further highlights the role that noncoding genes can have in genetic disorders.

The map was developed by using single-cell RNA sequencing to analyze 1.4 million plasma and immune cells in bone marrow from over 300 patients.

Pancreatic organoids reveal how lumen shape is controlled by the balance between cell proliferation, internal pressure, and epithelial permeability.

In this eBook, we explore the pros and cons of emerging and traditional proteomics technologies in terms of coverage and detail.

Under the agreement, Bionova will serve as the preferred manufacturing partner for Syenex’s best-in-class delivery platforms.

A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.

GEN’s first virtual event of 2026—we present a group of outstanding researchers and thought-leaders to discuss the latest advances and challenges in delivering genetic therapies.

Study identifies 1,376 genes linking psychiatric and skeletal disorders, with implications for early prevention strategies.